- Home
- MKDW vs CING Comparison
MKDW vs CING Comparison
Compare MKDW & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- CING
- Stock Information
- Founded
- MKDW 2006
- CING 2012
- Country
- MKDW Taiwan
- CING United States
- Employees
- MKDW N/A
- CING N/A
- Industry
- MKDW
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- MKDW
- CING Health Care
- Exchange
- MKDW NYSE
- CING Nasdaq
- Market Cap
- MKDW 15.4M
- CING 15.3M
- IPO Year
- MKDW N/A
- CING 2021
- Fundamental
- Price
- MKDW $0.54
- CING $4.76
- Analyst Decision
- MKDW
- CING Strong Buy
- Analyst Count
- MKDW 0
- CING 2
- Target Price
- MKDW N/A
- CING $12.00
- AVG Volume (30 Days)
- MKDW 667.4K
- CING 216.3K
- Earning Date
- MKDW 12-31-2024
- CING 11-07-2024
- Dividend Yield
- MKDW N/A
- CING N/A
- EPS Growth
- MKDW N/A
- CING N/A
- EPS
- MKDW N/A
- CING N/A
- Revenue
- MKDW N/A
- CING N/A
- Revenue This Year
- MKDW N/A
- CING N/A
- Revenue Next Year
- MKDW N/A
- CING N/A
- P/E Ratio
- MKDW N/A
- CING N/A
- Revenue Growth
- MKDW N/A
- CING N/A
- 52 Week Low
- MKDW $0.47
- CING $1.80
- 52 Week High
- MKDW $16.00
- CING $62.70
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- CING 52.86
- Support Level
- MKDW N/A
- CING $4.27
- Resistance Level
- MKDW N/A
- CING $5.16
- Average True Range (ATR)
- MKDW 0.00
- CING 0.42
- MACD
- MKDW 0.00
- CING -0.01
- Stochastic Oscillator
- MKDW 0.00
- CING 37.18
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.